159 related articles for article (PubMed ID: 34461182)
1. Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling.
He M; Yang H; Shi H; Hu Y; Chang C; Liu S; Yeh S
Cancer Lett; 2022 Jan; 524():15-28. PubMed ID: 34461182
[TBL] [Abstract][Full Text] [Related]
2. Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression.
Shi H; Sun Y; He M; Yang X; Hamada M; Fukunaga T; Zhang X; Chang C
Oncogene; 2020 Jan; 39(3):530-545. PubMed ID: 31501521
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer.
Yu W; Ding J; He M; Chen Y; Wang R; Han Z; Xing EZ; Zhang C; Yeh S
Oncogene; 2019 Feb; 38(8):1225-1238. PubMed ID: 30250297
[TBL] [Abstract][Full Text] [Related]
4. Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC.
Gu J; Zhang Y; Han Z; Gao L; Cui J; Sun Y; Niu Y; You B; Huang CP; Chang C; Wang X; Yeh S
Cell Death Dis; 2020 May; 11(5):367. PubMed ID: 32409702
[TBL] [Abstract][Full Text] [Related]
5. Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR.
You B; Sun Y; Luo J; Wang K; Liu Q; Fang R; Liu B; Chou F; Wang R; Meng J; Huang CP; Yeh S; Chang C; Xu W
Oncogene; 2021 Mar; 40(9):1674-1689. PubMed ID: 33510354
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.
Zhao X; Sun B; Liu T; Shao B; Sun R; Zhu D; Zhang Y; Gu Q; Dong X; Liu F; Zhao N; Zhang D; Li Y; Meng J; Gong W; Zheng Y; Zheng X
Cancer Sci; 2018 Oct; 109(10):3197-3208. PubMed ID: 30022558
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-SERB promotes vasculogenic mimicry (VM) formation and tumor metastasis in renal cell carcinoma.
Tang S; Chen F; Zhang J; Chang F; Lv Z; Li K; Li S; Hu Y; Yeh S
J Biol Chem; 2024 Apr; 300(5):107297. PubMed ID: 38641065
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.
Zhai W; Sun Y; Jiang M; Wang M; Gasiewicz TA; Zheng J; Chang C
Oncogene; 2016 Sep; 35(37):4866-80. PubMed ID: 26973243
[TBL] [Abstract][Full Text] [Related]
10. Estrogen receptor β upregulated by lncRNA-H19 to promote cancer stem-like properties in papillary thyroid carcinoma.
Li M; Chai HF; Peng F; Meng YT; Zhang LZ; Zhang L; Zou H; Liang QL; Li MM; Mao KG; Sun DX; Tong MY; Deng ZQ; Hou ZJ; Zhao Y; Li J; Wang XC; Lv SS; Zhang QQ; Yu X; Lam EW; Liu Q; Cui XN; Xu J
Cell Death Dis; 2018 Nov; 9(11):1120. PubMed ID: 30389909
[TBL] [Abstract][Full Text] [Related]
11. LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals.
Zhai W; Sun Y; Guo C; Hu G; Wang M; Zheng J; Lin W; Huang Q; Li G; Zheng J; Chang C
Cell Death Differ; 2017 Sep; 24(9):1502-1517. PubMed ID: 28644440
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.
Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J
J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232
[TBL] [Abstract][Full Text] [Related]
13. Targeting circDGKD Intercepts TKI's Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma.
Ding J; Cui XG; Chen HJ; Sun Y; Yu WW; Luo J; Xiao GQ; Chang C; Qi J; Yeh S
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406411
[TBL] [Abstract][Full Text] [Related]
14. Estrogen inhibits renal cell carcinoma cell progression through estrogen receptor-β activation.
Yu CP; Ho JY; Huang YT; Cha TL; Sun GH; Yu DS; Chang FW; Chen SP; Hsu RJ
PLoS One; 2013; 8(2):e56667. PubMed ID: 23460808
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network.
Ding J; Yeh CR; Sun Y; Lin C; Chou J; Ou Z; Chang C; Qi J; Yeh S
Oncogene; 2018 Sep; 37(37):5037-5053. PubMed ID: 29789714
[TBL] [Abstract][Full Text] [Related]
16. HOTAIR and androgen receptor synergistically increase GLI2 transcription to promote tumor angiogenesis and cancer stemness in renal cell carcinoma.
Bai JY; Jin B; Ma JB; Liu TJ; Yang C; Chong Y; Wang X; He D; Guo P
Cancer Lett; 2021 Feb; 498():70-79. PubMed ID: 33157157
[TBL] [Abstract][Full Text] [Related]
17. Restoring the epigenetically silenced PCK2 suppresses renal cell carcinoma progression and increases sensitivity to sunitinib by promoting endoplasmic reticulum stress.
Xiong Z; Yuan C; Shi J; Xiong W; Huang Y; Xiao W; Yang H; Chen K; Zhang X
Theranostics; 2020; 10(25):11444-11461. PubMed ID: 33052225
[No Abstract] [Full Text] [Related]
18. Extracellular Vesicle-Mediated Transfer of LncRNA IGFL2-AS1 Confers Sunitinib Resistance in Renal Cell Carcinoma.
Pan Y; Lu X; Shu G; Cen J; Lu J; Zhou M; Huang K; Dong J; Li J; Lin H; Song H; Xu Q; Han H; Chen Z; Chen W; Luo J; Wei J; Zhang J
Cancer Res; 2023 Jan; 83(1):103-116. PubMed ID: 36264173
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor beta increases clear cell renal cell carcinoma stem cell phenotype via altering the circPHACTR4/miR-34b-5p/c-Myc signaling.
Wang Y; Yang Z; Gu J; Zhang Y; Wang X; Teng Z; Wang D; Gao L; Li W; Yeh S; Han Z
FASEB J; 2022 Feb; 36(2):e22163. PubMed ID: 35061326
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression.
Zhao D; Wang S; Chu X; Han D
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1342-1348. PubMed ID: 30966832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]